Unlike melatonin, DSIP remains experimental and has much less clinical evidence supporting its use
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Villena JA, Roy S, Sarkadi-Nagy E, Kim K-H, Sul HS
Phenotypic screening is the pragmatic alternative: apply the peptide to a relevant cell system and measure broad outputs, transcriptome by RNA-seq, proteome, or metabolic and viability panels, without presupposing a target
180(2): 251 Warner MA, Mauermann WJ, Armour S, Barbara DW
There are currently ongoing observational studies and early-phase clinical investigations of BPC-157 in gastrointestinal disease, reflecting the strength of the gut healing literature and the relative accessibility of GI endpoints in human trials